Current role
Minji Kim, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Minji Kim, Ph.D.
Mineralys Therapeutics, Inc. reported in an 8-K filed January 4, 2024 that Minji Kim, Ph.D. was appointed Chief Business Officer, effective January 4, 2024.
“On January 4, 2024, in connection with the appointment of Minji Kim, Ph.D., as Chief Business Officer, the Board of Directors of Mineralys Therapeutics, Inc. (the "Company") approved splitting the functions of Chief Financial Officer and Chief Business Officer into two roles.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mineralys Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jon Congleton CEO, Board Member
- Glenn P. Sblendorio Chairman
- Alexander Gold Board Member
- Alexander M. Gold, M.D. Board Member
- Brian Taylor Slingsby Board Member
- Daphne Karydas Board Member
- Derek DiRocco Board Member
- Srinivas Akkaraju Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.